مجله سلامت و ورزش: رویکردهای نوین (سورن)

1Barton M, Meyer MR. Postmenopausal hypertension: mechanisms and therapy. Hypertension 54: 11– 18, 2009. doi:10.1161 YPERTENSIONAHA.108.120022.
2. Black M A, Cable N T, Green D J. Impact of age, sex, and exercise on brachial artery flow-mediated dilatation. Am J Physiol Heart Circ Physiol. 2009; 297: 1109-15.
3. Blair S N, Goodyear N N, Gibbons L W, Cooper Kh. Physical fitness and incidence of hypertension in healthy normotensive men and women. JAMA. 1984; 252(4): 487-90.
4. Blair S N, Goodyear N N, Cooper Kh. Physical fitness and incidence of hypertension in healthy normotensive men and women. JAMA. 1984; 252(4): 487-90.
5. Currie K D, McKelvie R S. Flow-mediated dilation is acutely improved after high-intensity interval exercise. Med Sci Sports Exerc. 2012; 44(11): 2057-64.
6. Dubey RK, Imthurn B, Jackson EK. Vascular consequences of menopause and hormone therapy: importance of timing of treatment and type of estrogen. Cardiovasc Res 66: 295–306, 2005. doi:10.1016/j.cardiores.2004.12.012.
7. Dawson EA, Green DJ, Cable NT, Thijssen DH. Effects of acute exercise on flow-mediated dilatation in healthy humans. J Appl Physiol(1985) 115: 1589–1598, 2013.
8. Emmanuel G C, Luiz A B. Effects of high-intensity aerobic interval training vs. moderate exercise on hemodynamic, metabolic and neuro-humoral abnormalities of young normotensive women at high familial risk for hypertension. Hypertension Research. 2010; 72(10).
9. Franklin NC, Ali M, Wang E, Phillips SA. Reduced vasodilator function following acute resistance exercise in obese women. Front Physiol 5: 253, 2014.
10. Green DJ, Hopkins ND, Thijssen DH, Eijsvogels TM, Yeap BB. Sex differences in vascular endothelial function and health in humans: Exp Physiol 101:230–242,2016.doi:10.1113/EP085367.
11. Harris RA, Padilla J, Rink LD, Wallace JP. The flow- mediated dilation response to acute exercise in overweight active and inactive men. Obesity (Silver Spring) 16: 578–584, 2008.
12. Harvey PJ, Picton PE, Notarius CF. Exercise as an alternative to oral estrogen for amelioration of endothelial dysfunction in postmenopausal women. Am Heart J 149: 291–297, 2005.
13. Lakatta EG, Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part I: aging arteries: a “set up” for vascular disease. Circulation 107: 139–146, 2003. doi:10.1161/01.CIR.0000048892.83521.58.
14. Matthews KA, Crawford SL, Everson-Rose SA, Sowers MF, Sternfeld B, Sutton-Tyrrell K. Are changes in cardiovascular disease risk factors in midlife women due to chronological aging or to the menopausal transition? J Am Coll Cardiol 54:2366–2373,2009.doi:10.1016/j.jacc.2009.10.009.
15. Moreau KL, Hildreth KL, Deane KD, Kohrt WM. Endothelial function is impaired across the stages of the menopause transition in healthy women. J Clin Endocrinol 97: 4692–4700, 2012.
16. Moreau KL, Stauffer BL, Seals DR. Essential role of estrogen for improvements in vascular endothelial function with endurance exercise in postmenopausal women. J Clin Endocrinol Metab 98: 4507–4515, 2013.
17. Mercuro G, Longu G, Cherchi A. Impaired forearm blood flow and vasodilator reserve in healthy postmenopausal women. Am Heart J 137: 692–697, 1999.
18. Padilla J, Harris Wallace JP RA. Can the measurement of brachial artery flow-mediated dilation be applied to the acute exercise model. Cardiovasc Ultrasound 5: 45, 2007.
19. Reis SE, Holubkov R, Kelsey SF, Sharaf BL, Reichek N, Rogers WJ, Merz CN, Sopko G, Pepine CJ;WISE Investigators.Coronary microvascular dysfunction is highly prevalent in women with chest pain in the absence of coronary artery disease: results from the NHLBI WISE study. Am Heart J 141: 735–741, 2001. doi:10.1067/mhj.2001.114198.